Syndax Pharmaceuticals, Inc. (SNDX)
9.54
+0.17
(+1.81%)
USD |
NASDAQ |
Nov 06, 16:00
9.79
+0.25
(+2.62%)
After-Hours: 20:00
Syndax Pharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2026 | 107.66 |
| September 28, 2026 | 105.45 |
| September 25, 2026 | 107.46 |
| September 24, 2026 | 106.10 |
| September 23, 2026 | 104.15 |
| September 22, 2026 | 107.37 |
| September 21, 2026 | 106.69 |
| September 18, 2026 | 104.03 |
| September 17, 2026 | 104.39 |
| September 16, 2026 | 102.03 |
| September 15, 2026 | 106.81 |
| September 14, 2026 | 108.34 |
| September 11, 2026 | 107.34 |
| September 10, 2026 | 111.12 |
| September 09, 2026 | 117.14 |
| September 08, 2026 | 117.73 |
| September 04, 2026 | 121.39 |
| September 03, 2026 | 122.10 |
| September 02, 2026 | 122.69 |
| September 01, 2026 | 118.68 |
| August 31, 2026 | 113.89 |
| August 28, 2026 | 115.37 |
| August 27, 2026 | 119.03 |
| August 26, 2026 | 118.62 |
| August 25, 2026 | 117.61 |
| Date | Value |
|---|---|
| August 24, 2026 | 115.55 |
| August 21, 2026 | 116.02 |
| August 20, 2026 | 116.61 |
| August 19, 2026 | 122.63 |
| August 18, 2026 | 117.58 |
| August 17, 2026 | 116.67 |
| August 14, 2026 | 117.14 |
| August 13, 2026 | 112.65 |
| August 12, 2026 | 116.90 |
| August 11, 2026 | 119.80 |
| August 10, 2026 | 120.27 |
| August 07, 2026 | 120.45 |
| August 06, 2026 | 116.67 |
| August 05, 2026 | 117.61 |
| August 04, 2026 | 112.65 |
| August 03, 2026 | 113.60 |
| July 31, 2026 | 112.48 |
| July 30, 2026 | 115.01 |
| July 29, 2026 | 113.48 |
| July 28, 2026 | 115.90 |
| July 27, 2026 | 121.16 |
| July 24, 2026 | 122.87 |
| July 23, 2026 | 125.23 |
| July 22, 2026 | 130.19 |
| July 21, 2026 | 133.67 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.797 |
| Emergent BioSolutions, Inc. | 0.9926 |
| Incyte Corp. | 4.326 |
| Vertex Pharmaceuticals, Inc. | 6.634 |
| Travere Therapeutics, Inc. | 210.13 |
Price to Book Value Related Metrics
| PS Ratio | 2.918 |
| Price | 9.54 |
| Earnings Yield | -24.81% |
| Market Cap | 858.50M |